This book provides a detailed review of the role of health technology
assessment (HTA) in the European Union. It examines both method and
process in the prioritization and financing of modern health care and
presents extensive case studies from Sweden, the Netherlands, Finland,
France, Germany and the United Kingdom.
The book examines a number of issues, with particular emphasis on the
responsibility and membership of HTA bodies' assessment procedures and
methods, the application of HTA evidence to decision-making, and the
dissemination and implementation of findings. It aims to highlight ways
to improve the HTA process in Europe by examining key challenges and
identifying opportunities to support value and innovation in health
care.
It will be vital reading for a wide range of stakeholders including
policy-makers, HTA bodies, manufacturers, health-care professionals and
patient organizations.